XML 40 R28.htm IDEA: XBRL DOCUMENT v3.22.1
STOCK INCENTIVE PLANS (Tables)
3 Months Ended
Mar. 31, 2022
Employee Benefits And Share Based Compensation [Abstract]  
Schedule of Performance Units outstanding
The following
 
table presents
 
information
 
related to
 
Performance
 
Units outstanding
 
during the
 
three months
 
ended March
 
31, 2022 and
2021.
($ in thousands, except per share data)
Three Months Ended March 31,
2022
2021
Weighted
Weighted
Average
Average
Grant Date
Grant Date
 
Shares
Fair Value
Shares
Fair Value
Unvested, beginning of period
133,223
$
5.88
4,554
$
7.45
Granted
175,572
3.31
137,897
5.88
Vested and issued
(13,322)
5.88
(2,277)
7.45
Unvested, end of period
295,473
$
4.35
140,174
$
5.91
Compensation expense during period
$
106
$
3
Unrecognized compensation expense, end of period
$
942
$
812
Intrinsic value, end of period
$
960
$
842
Weighted-average remaining vesting term (in years)
1.8
2.1
Schedule of Fully Vested Deferred Stock Units
The following
 
table presents
 
information
 
related to
 
fully vested
 
common stock
issued during
 
the three
 
months ended
 
March 31,
 
2022 and
 
2021. All
 
of the fully
 
vested shares
 
of common
 
stock issued
 
during the
 
three
months ended
 
March 31,
 
2022 and
 
2021, and
 
the related
 
compensation
 
expense, were
 
granted with
 
respect to
 
service performed
 
during
the fiscal
 
years ended
 
December
 
31, 2021
 
and 2020,
 
respectively.
($ in thousands, except per share data)
Three Months Ended March 31,
2022
2021
Fully vested shares granted
175,572
137,897
Weighted average grant date price per share
$
3.31
$
5.88
Compensation expense related to fully vested shares of common stock awards
$
581
$
811
Schedule of Stock Awards
The following
 
table presents
 
information
 
related to
 
the DSUs
 
outstanding
 
during the
 
three months
 
ended March
 
31, 2022
 
and 2021.
($ in thousands, except per share data)
Three Months Ended March 31,
2022
2021
Weighted
Weighted
Average
Average
Grant Date
Grant Date
 
Shares
Fair Value
Shares
Fair Value
Outstanding, beginning of period
142,976
$
5.38
90,946
$
5.44
Granted and vested
15,273
4.39
10,422
5.31
Outstanding, end of period
158,249
$
5.29
101,368
$
5.43
Compensation expense during period
$
75
$
45
Intrinsic value, end of period
$
514
$
609